NCT00322855

Brief Summary

To review the outcome of patients with soft tissue sarcoma treated with chemotherapy from 2004 and 2005.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Aug 2005

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2005

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

May 5, 2006

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 8, 2006

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2007

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2007

Completed
7.9 years until next milestone

Results Posted

Study results publicly available

July 9, 2015

Completed
Last Updated

July 31, 2015

Status Verified

July 1, 2015

Enrollment Period

1.9 years

First QC Date

May 5, 2006

Results QC Date

June 16, 2015

Last Update Submit

July 10, 2015

Conditions

Sarcoma

Outcome Measures

Primary Outcomes (1)

  • To Review the Outcome of Patients With Soft Tissue Sarcoma Treated With Chemotherapy From 2004 and 2005

    up to one year

Study Arms (1)

Chart Review

patients diagnosed with soft tissue sarcoma

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients with soft tissue sarcoma treated with chemotherapy form 2004 and 2005.

You may qualify if:

  • Patients diagnosed with soft tissue sarcoma treated with chemotherapy form 2004 and 2005.

You may not qualify if:

  • Not Specified

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of New Mexico

Albuquerque, New Mexico, 87131, United States

Location

MeSH Terms

Conditions

Sarcoma

Condition Hierarchy (Ancestors)

Neoplasms, Connective and Soft TissueNeoplasms by Histologic TypeNeoplasms

Results Point of Contact

Title
Christine M. Gan, Ph.D
Organization
University of New Mexico
cgan@salud.unm.edu
5059250387

Study Officials

  • Aroop Mangalik, MD

    University of New Mexico

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 5, 2006

First Posted

May 8, 2006

Study Start

August 1, 2005

Primary Completion

July 1, 2007

Study Completion

August 1, 2007

Last Updated

July 31, 2015

Results First Posted

July 9, 2015

Record last verified: 2015-07

Locations

US(1)